Apnar Pharma Private Limited - Company overview

Apnarpharma was incorporated on 12 December 2014 and is registered with ROC Ahmedabad.

2014-12-12 Padra, Gujarat Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹25–50 Cr
▲ 83.7%
FY 2024
PROFIT / LOSS
₹1–10 Lakh
▼ -88.9%
FY 2024
EBITDA
₹5–10 Cr
▲ 81.7%
FY 2024
NET WORTH
₹1–5 Cr
▲ 6.2%
FY 2024
TOTAL ASSETS
₹50–100 Cr
▲ 41.6%
FY 2024
EMPLOYEE COUNT
91–100
OPEN CHARGES
6
50.35 cr
PAID-UP CAPITAL
7.55 cr
AUTHORISED CAPITAL
7.60 cr
COMPANY AGE
11 Years 11 Months
since 2014-12-12
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-30
ACTIVE GST
1
Updated: 2025-02-27 16:59:44
TOTAL MONEY RAISED
₹1–5 Cr
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Apnarpharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
86/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (81), financial health (85), director (90) and company-foundation signals.
  • Operating for 11+ years.
Compliance Score Low risk
81/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
85/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2024.
  • Positive net worth.
Director Risk Score Low risk
90/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Apnarpharma Company identity, industry, contact, and registration details from MCA and company records.

Apnarpharma was incorporated on 12 December 2014 and is registered with ROC Ahmedabad. It is an active private limited company, now about 11 years old. The registered office is in Padra, Gujarat. It was earlier known as Apnar Research Pharma Private Limited.

In its MCA filings the main business is listed as scientific research and development, which made up 100% of turnover.

It has three directors: Umesh Patel, Dharmesh Bhikhabhai Patel and Swapnil Kantibhai Patel. The longest-serving is Swapnil Kantibhai Patel, on the board since 2014; the most recent to join is Umesh Patel, appointed in February 2015. Two former directors are on record; the most recent to leave was Kantibhai Bavabhai Patel in September 2024.

₹7.55 crore of its ₹7.6 crore authorised capital is paid up (about 99%). Its latest balance sheet on MCA is for the year ending 31 March 2025, and the last AGM was on 30 September 2025. Six charges (secured loans) are still open, with Hdfc Bank Limited among the lenders.

Pharma ••••••••
  • Location Block No. 102, At & Po. Gavasad, Padra Jambusar Road,, Padra, Gujarat - 391430
  • Website apnarpharma.com
Name History
Legal NameApnar Pharma Private Limited
CIN / LLPINU73100GJ2014PTC081520
Company No.081520
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2014-12-12
Date of AGM2025-09-30
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Ahmedabad
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Apnarpharma (3) Current board members from MCA filings, including designation and appointment details.

U
Director | Since 2015-02-25 | DIN: 07094819
D
Director | Since 2015-01-24 | DIN: 07022276
S
Director | Since 2014-12-12 | DIN: 06952743

Financial Performance of Apnarpharma Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2024
Revenue ₹25–50 Cr ▲ 83.7%
P&L ₹1–10 Lakh ▼ -88.9%
EBITDA ₹5–10 Cr ▲ 81.7%
Net worth ₹1–5 Cr ▲ 6.2%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Apnarpharma Open and satisfied charges registered against the company with MCA.

Others : 21.49 cr
Hdfc Bank Limited : 19.87 cr
Open Charges: 6 Satisfied Charges: 0
Open 50.35 cr
Satisfied 0
LenderAmountStatus
Others
Creation Date: 29 Jun 2022
7.50 cr Open
Others
Creation Date: 09 Dec 2021
83.38 Lakh Open
Others
Creation Date: 24 Aug 2020
1.66 cr Open

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
Professional, Scientific and TechnicalScientific research and development100

Financial Ratios of Apnarpharma Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

9 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Apnarpharma Ownership and contribution detail from filings. Full breakdown unlocks with your report.

10 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Apnarpharma EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Apnarpharma GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Apnarpharma Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Apnarpharma MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Apnarpharma Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apnarpharma Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Apnarpharma?
MCA does not publish an "owner" field. Apnarpharma is run by its directors, Umesh Patel, Dharmesh Bhikhabhai Patel and Swapnil Kantibhai Patel. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Apnarpharma?
Apnarpharma has three current directors: Umesh Patel (since February 2015), Dharmesh Bhikhabhai Patel (since January 2015) and Swapnil Kantibhai Patel (since December 2014).
What is CIN of Apnarpharma?
The CIN of Apnarpharma is U73100GJ2014PTC081520. Reading it left to right: U means it is not listed, 73100 is the industry code it registered under, GJ is Gujarat, 2014 is the year it was registered, PTC is the company type and 081520 is its registration number.
When was Apnarpharma incorporated?
Apnarpharma was incorporated on 12 December 2014 with ROC Ahmedabad. That makes it about 11 years old.
What is the registered address of Apnarpharma?
The registered office on MCA records is Block No. 102, At & Po. Gavasad, Padra Jambusar Road, Padra, Gujarat - 391430.
What is the current status of Apnarpharma?
MCA shows Apnarpharma as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Apnarpharma?
You can post to its registered office at Block No. 102, At & Po. Gavasad, Padra Jambusar Road, Padra, Gujarat - 391430 and use its website, https://apnarpharma.com.
What industry or business activity is Apnarpharma associated with?
Its MCA filings list the main business as scientific research and development (100% of turnover).
What is paid-up capital and authorised share capital of Apnarpharma?
Paid-up capital is ₹7.55 crore and authorised capital is ₹7.6 crore, so about 99% of the authorised amount has been issued.
When did Apnarpharma last file accounts and hold an AGM?
The last AGM on record was on 30 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Apnarpharma?
Six charges against Apnarpharma are still open. Lenders named in the filings include Hdfc Bank Limited.
Have any directors left Apnarpharma?
Yes, two former directors are on record. The most recent to leave were Kantibhai Bavabhai Patel (September 2024) and Bhavesh Kishor Jagtap (August 2023).
What is the turnover or revenue of Apnarpharma?
Based on filed financial statements, the revenue of Apnarpharma for FY 2024 was in the ₹25–50 Cr range. That is up 83.7% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Apnarpharma?
For FY 2024, the net worth of Apnarpharma was in the ₹1–5 Cr range.
How can I get the financial details of Apnarpharma?
The latest accounts on record are for FY 2024. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Apnarpharma?
The website on record for Apnarpharma is https://apnarpharma.com.
Which company owns apnarpharma.com?
apnarpharma.com is the website listed for Apnar Pharma Private Limited in its company records.
Apnarpharma - is it listed or unlisted?
Apnarpharma is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Apnarpharma?
Apnarpharma is registered with ROC Ahmedabad.
What is the company classification of Apnarpharma?
MCA classifies Apnarpharma as: Private Limited Indian Non-Government Company.
Does Apnarpharma have GST registrations on file?
Yes, one active GST registration is linked to Apnarpharma.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.